APA (7th ed.) Citation

Yang, C., Lin, L., Lin, Y., Tian, Y., Lin, C., Sheu, M., . . . Tai, M. (2019). Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression. Oncology Letters, 17(2), 1551.

Chicago Style (17th ed.) Citation

Yang, Ching-Chieh, Li-Ching Lin, Yu-Wei Lin, Yu-Feng Tian, Chen-Yi Lin, Ming-Jen Sheu, Chien-Feng Li, and Ming-Hong Tai. "Higher Nuclear EGFR Expression Is a Better Predictor of Survival in Rectal Cancer Patients Following Neoadjuvant Chemoradiotherapy than Cytoplasmic EGFR Expression." Oncology Letters 17, no. 2 (2019): 1551.

MLA (9th ed.) Citation

Yang, Ching-Chieh, et al. "Higher Nuclear EGFR Expression Is a Better Predictor of Survival in Rectal Cancer Patients Following Neoadjuvant Chemoradiotherapy than Cytoplasmic EGFR Expression." Oncology Letters, vol. 17, no. 2, 2019, p. 1551.